|
|
Volumn 113, Issue 7, 2006, Pages 1020-1033
|
|
Hemodynamic goals are relevant
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
SPIRONOLACTONE;
VASODILATOR AGENT;
CARDIOGENIC SHOCK;
CARDIOVASCULAR RISK;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMORBIDITY;
CONGESTIVE HEART FAILURE;
DEFIBRILLATION;
DEFIBRILLATOR;
DISEASE COURSE;
DYSPNEA;
HEART EJECTION FRACTION;
HEART FAILURE;
HEART OUTPUT;
HEART TRANSPLANTATION;
HEMODYNAMICS;
HOSPITAL DISCHARGE;
HOSPITALIZATION;
HUMAN;
KIDNEY FUNCTION;
MORTALITY;
OUTCOME ASSESSMENT;
OUTPATIENT CARE;
PHENOTYPE;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
SOCIAL PSYCHOLOGY;
SURVIVAL;
BLOOD PRESSURE;
DISEASE MANAGEMENT;
PATHOPHYSIOLOGY;
PROGNOSIS;
BLOOD PRESSURE;
DISEASE MANAGEMENT;
HEART FAILURE, CONGESTIVE;
HEMODYNAMIC PROCESSES;
HOSPITALIZATION;
HUMANS;
PROGNOSIS;
|
|
EID: 33645058195
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.104.478321 Document Type: Review |
|
Times cited : (72)
|
|
References (0)
|
